D. Boral Capital downgraded HeartBeam (BEAT) to Hold from Buy without a price target following the company’s’ capital raise. The “deal size and terms represent a strategic misstep,” the analyst tells investors in a research note. The firm says the equity raise structure, which was priced at a significant discount and pushed the stock below $1.00, “introduces both technical and psychological overhangs.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAT:
- HeartBeam (NASDAQ: BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization
- HeartBeam Raises Capital to Advance Cardiac Monitoring Technologies
- HeartBeam (NASDAQ: BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives
- HeartBeam 12.5M share Spot Secondary priced at 80c
- HeartBeam announces common stock offering, no amount given
